Your browser doesn't support javascript.
loading
Design, Synthesis, and Anti-Prostrate Cancer Potential of 2-(4-nitrobenzyl) malonates In Vitro and DAL Acute Oral Toxicity Assessment In Vivo.
Ganesh, Bharathi Hassan; Aruchamy, Baladhandapani; Mudradi, Srikrishna; Mohanty, Sarthak; Padinjarathil, Himabindu; Carradori, Simone; Ramani, Prasanna.
Afiliación
  • Ganesh BH; Amrita Vishwa Vidyapeetham, Department of Chemistry, INDIA.
  • Aruchamy B; Amrita Vishwa Vidyapeetham, Department of Chemistry, INDIA.
  • Mudradi S; Amrita Vishwa Vidyapeetham, Department of Chemistry, INDIA.
  • Mohanty S; Amrita Vishwa Vidyapeetham, Department of Chemistry, INDIA.
  • Padinjarathil H; Amrita Vishwa Vidyapeetham, Department of Chemistry, INDIA.
  • Carradori S; Gabriele d'Annunzio University of Chieti and Pescara, Department of Pharmacy, ITALY.
  • Ramani P; Amrita Vishwa Vidyapeetham, Department of Sciences, Dhanvanthri Lab, Ettimadai, 641112, Coimbatore, INDIA.
ChemMedChem ; : e202400371, 2024 Aug 05.
Article en En | MEDLINE | ID: mdl-39101815
ABSTRACT
New 4-nitrobenzyl derivatives were designed and synthesised by nucleophilic substitution reactions of 4-nitrobenzyl bromide with malonic acid and its derivatives. The synthesised molecules were characterised using mass analysis and spectroscopic techniques and tested for their antioxidant properties using various methods, such as nitric oxide, DPPH, and hydrogen peroxide radical scavenging methods. The anti-inflammatory activities of the molecules were assessed using RBC membrane stabilisation and albumin denaturation methods. We evaluated the compounds' potential anti-prostate cancer activity using the DU145 cell line. The MTT assay determined the cell viability, indicating good anti-proliferative activity. The molecule 3c exhibited the highest potency, with a CTC50 of 11.83 µg/mL. Molecular dynamics simulations were performed to study the stability of the ligand within the protein after docking and the resulting protein-ligand complex. The in vivo analysis of molecule 3c in the DAL xenograft model demonstrated promising results. The increase in life span, reduction in tumor volume, and comparable effects to standard drugs are encouraging features that suggest that molecule 3c may possess significant potential as an anti-cancer agent. The research also implies that these molecules might be potential lead compounds for developing new prostate cancer drugs.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ChemMedChem Asunto de la revista: FARMACOLOGIA / QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: India Pais de publicación: Alemania